期刊文献+

2013年肾脏疾病主要临床进展 被引量:8

Clinical main advances in kidney disease researches during 2013
下载PDF
导出
摘要 目的综述了2013年改善全球肾脏病预后组织(KIDGO)慢性肾脏病脂质处理临床实践指南、中国肾性贫血的诊断与治疗专家共识以及难治性高血压诊断治疗中国专家共识。回顾了狼疮性肾炎,特发性膜性肾病,IgA肾病和糖尿病肾病等肾小球疾病治疗,易致急性肾损伤的药物,高磷血症,肾性贫血和血液净化的治疗进展。 To sum up the KDIGO clinical practice guideline for lipid management in chronic kidney disease,the expert consenus for diagnosis and treatment of renal anemia and resistent hypertension in China.To review the treatment of glomerular diseases,such as lupus nephritis,idiopathic membranous nephropathy,IgA nephropathy,diabetic nephropathy and so on,the drugs which easily lead to acute kidney injury,the progress in treatment of renal anemia,hyperphosphatemia and blood purification.
作者 傅淑霞
出处 《临床荟萃》 CAS 2014年第3期252-260,共9页 Clinical Focus
关键词 狼疮肾炎 肾小球肾炎 膜性 肾小球肾炎 IGA 糖尿病肾病 lupus nephritis glomerulonephritis, membranous glomerulonephritis, IGA diabetic nephropathies
  • 相关文献

参考文献44

  • 1no author. KDIGO clinical practice guideline for lipid management in chronic kidney disease[J].Kidney International,2013,(Suppl 3):262-296. 被引量:1
  • 2肾性贫血诊断与治疗中国专家共识[J].中华肾脏病杂志,2013,29(5):389-392. 被引量:67
  • 3孙宁玲,霍勇,王继光,李南方,陶军,李勇,严晓伟,蒋雄京,李学旺.难治性高血压诊断治疗中国专家共识[J].中华高血压杂志,2013,21(4):321-326. 被引量:152
  • 4Condon MB,Ashby D,Pepper RJ. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids[J].ANNALS OF THE RHEUMATIC DISEASES,2013,(08):1280-1286. 被引量:1
  • 5Walsh M,Solomons N,Lisk L. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function:a subgroup analysis of the Aspreva Lupus Management Study[J].American Journal of Kidney Disease,2013,(05):710-715. 被引量:1
  • 6Davies RJ,Sangle SR,Jordan NP. Rituximab in the treatment of resistant lupus nephritis:therapy failure in rapidly progressive crescentic lupus nephritis[J].LUPUS,2013,(06):574-582. 被引量:1
  • 7王彬,杨敏,李曼,刘华,邹芸,潘家荣.他克莫司和环磷酰胺治疗狼疮肾炎的Meta分析[J].中华肾脏病杂志,2013,29(4):248-252. 被引量:7
  • 8Busch M,Rüster C,Schink(o)the C. Rituximab for the second-and third-line therapy of idiopathic membranous nephropathy:a prospective single center study using a new treatment strategy[J].Clinical Nephrology,2013,(02):105-113. 被引量:1
  • 9Sengupta U,Kumar V,Yadav AK. Infusion of autologous bone marrow mononuclear cells leads to transient reduction in proteinuria in treatment refractory patients with idiopathic membranous nephropathy[J].BMC Nephrology,2013.262. 被引量:1
  • 10Howman A,Chapman TL,Langdon MM. Immunosuppression for progressive membranous nephropathy:a UK randomised controlled trial[J].LANCET,2013,(9868):744-751. 被引量:1

二级参考文献56

  • 1章海涛,胡伟新,谢红浪,曾彩虹,陈惠萍,刘志红,黎磊石.普乐可复与环磷酰胺诱导治疗Ⅳ型狼疮性肾炎的疗效比较[J].肾脏病与透析肾移植杂志,2006,15(6):501-507. 被引量:28
  • 2章海涛,胡伟新,谢红浪,曾彩虹,陈惠萍,刘志红,黎磊石.前瞻性比较普乐可复与环磷酰胺诱导治疗Ⅴ型伴Ⅳ型狼疮性肾炎的疗效[J].肾脏病与透析肾移植杂志,2006,15(6):508-514. 被引量:20
  • 3Karim Y, D^Cruz DP. The NIH pulse cyclophosphamideregime: the end of an era. Lupus, 2004, 13: 1-3. 被引量:1
  • 4Lee T, Oh KH, Joo KW, et al. Tacrolimus is an alternativetherapeutic option for the treatment of refractory lupusnephritis. Lupus, 2010, 19: 974-980. 被引量:1
  • 5Ginzler EM. Clinical trials in lupus nephritis. Curr RheumatolRep, 2001, 3: 199-204. 被引量:1
  • 6Houssiau FA, Lefebvre C, Vanden BM, et al. Seruminterleukin 10 titers in systemic lupus erythematosus reflectdisease activity. Lupus, 1995,4: 393-395. 被引量:1
  • 7Chen W,Tang X, Liu Q,et al. Short - term outcomes ofinduction therapy with tacrolimus versus cyclophosphamidefor active lupus nephritis: A multicenter randomized clinicaltrial. Am J Kidney Dis, 2011, 57: 235-244. 被引量:1
  • 8Wang S, Li X, Qu L, et al. Tacrolimus versuscyclophosphamide as treatment for diffuse proliferative ormembranous lupus nephritis: a non - randomized prospectivecohort study. Lupus, 2012, 21: 1025-1035. 被引量:1
  • 9Li X, Ren H, Zhang Q, et al. Mycophenolate mofetil ortacrolimus compared with intravenous cyclophosphamide in theinduction treatment for active lupus nephritis. Nephrol DialTransplant, 2012,27: 1467-1472. 被引量:1
  • 10Cameron JS. Lupus nephritis. J Am Soc Nephrol,1999, 10: 413-424. 被引量:1

共引文献230

同被引文献95

引证文献8

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部